Sarepta Therapeutics (SRPT) Technical (Analysis) Reports Sarepta Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Sarepta Therapeutics (SRPT)
Technical Analysis Report for NASDAQ stock SRPT Sarepta Therapeutics. Dated: 02 Mar 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock SRPT Sarepta Therapeutics then click here. or read Experts views on Sarepta Therapeutics or Forecast & share price targets of Sarepta Therapeutics
Sarepta Therapeutics Opened at 16.28 and Closed at: 16.32, which is -2.7% of previous session's close. It moved within a range of 15.84 and 16.68
The session was a Bullish session with an average volume of 2510200, which is -4.39% of previous session's volumes.
- The stock has fallen, and its short term trend is also negative and in a downtrend.
- The stock has fallen, and its mid term trend is also negative and in a downtrend.
- The stock has fallen, and its long term trend is also negative and in a downtrend.
Support for tomorrow is 16.08 and resistance for tomorrow is 16.92
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 15.88, 15.44 resistance for tomorrow's hourly charts is 16.72, 17.12
10 Day SMA for Sarepta Therapeutics (SRPT) is 18.02 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Sarepta Therapeutics (SRPT) is 18.17 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Sarepta Therapeutics (SRPT) is 20.28 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 20.58 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Sarepta Therapeutics is 21.61 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Sarepta Therapeutics is at 18.17 and 200 DMA is at 21.61, while 50 DMA and 100 DMA are at 20.28 and 20.58 respectively
Sarepta Therapeutics (SRPT) moving average of 20 SMA is at 18.17 and 20 EMA is at 18.42
| Date | Closing Price | 20 SMA | 20 EMA |
| 02 Mon Mar | 16.32 | 18.17 | 18.42 |
| 27 Fri Feb | 16.76 | 18.39 | 18.64 |
| 26 Thu Feb | 17.46 | 18.56 | 18.84 |
| 25 Wed Feb | 18.97 | 18.75 | 18.98 |
| 24 Tue Feb | 18.84 | 18.87 | 18.98 |
| 23 Mon Feb | 18.12 | 19.04 | 19 |
Sarepta Therapeutics (SRPT) moving average of 50 SMA is at 20.28 and 50 EMA is at 19.54
| Date | Closing Price | 50 SMA | 50 EMA |
| 02 Mon Mar | 16.32 | 20.28 | 19.54 |
| 27 Fri Feb | 16.76 | 20.38 | 19.67 |
| 26 Thu Feb | 17.46 | 20.49 | 19.79 |
| 25 Wed Feb | 18.97 | 20.57 | 19.88 |
| 24 Tue Feb | 18.84 | 20.62 | 19.92 |
| 23 Mon Feb | 18.12 | 20.68 | 19.96 |
Sarepta Therapeutics (SRPT) moving average of 100 SMA is at 20.58 and 100 EMA is at 21.23
| Date | Closing Price | 100 SMA | 100 EMA |
| 02 Mon Mar | 16.32 | 20.58 | 21.23 |
| 27 Fri Feb | 16.76 | 20.64 | 21.33 |
| 26 Thu Feb | 17.46 | 20.71 | 21.42 |
| 25 Wed Feb | 18.97 | 20.76 | 21.5 |
| 24 Tue Feb | 18.84 | 20.8 | 21.55 |
| 23 Mon Feb | 18.12 | 20.8 | 21.6 |
Sarepta Therapeutics (SRPT) moving average of 200 SMA is at 21.61 and 200 EMA is at 32.42
| Date | Closing Price | 200 SMA | 200 EMA |
| 02 Mon Mar | 16.32 | 21.61 | 32.42 |
| 27 Fri Feb | 16.76 | 21.71 | 32.58 |
| 26 Thu Feb | 17.46 | 21.81 | 32.74 |
| 25 Wed Feb | 18.97 | 21.9 | 32.89 |
| 24 Tue Feb | 18.84 | 21.99 | 33.03 |
| 23 Mon Feb | 18.12 | 22.08 | 33.17 |
Tiziana Life has performed better than Sarepta Therapeutics in short term. You could have earned much better returns by investing in Tiziana Life, about 21.54% more returns!
Tactile Systems has performed better than Sarepta Therapeutics in short term. You could have earned much better returns by investing in Tactile Systems, about 23.28% more returns!
Pulse Biosciences has performed better than Sarepta Therapeutics in short term. You could have earned much better returns by investing in Pulse Biosciences, about 53.75% more returns!
Pavmed Inc has performed better than Sarepta Therapeutics in short term. You could have earned much better returns by investing in Pavmed Inc, about 24.72% more returns!
Ocular Therapeutix has performed better than Sarepta Therapeutics in short term. You could have earned much better returns by investing in Ocular Therapeutix, about 48.51% more returns!
Natera Inc has performed better than Sarepta Therapeutics in short term. You could have earned much better returns by investing in Natera Inc, about 7.46% more returns!
Minerva Neurosciences has performed better than Sarepta Therapeutics in short term. You could have earned much better returns by investing in Minerva Neurosciences, about 59.45% more returns!
Sarepta Therapeutics has performed better than Moleculin Biotech in short term. Holding Sarepta Therapeutics could be a better choice for now!
Lifevantage Corporation has performed better than Sarepta Therapeutics in short term. You could have earned much better returns by investing in Lifevantage Corporation, about 3.82% more returns!
Kura Oncology has performed better than Sarepta Therapeutics in short term. You could have earned much better returns by investing in Kura Oncology, about 24.96% more returns!
Acadia Healthcare has performed better than Sarepta Therapeutics in short term. You could have earned much better returns by investing in Acadia Healthcare, about 90.84% more returns!
Compugen has performed better than Sarepta Therapeutics in short term. You could have earned much better returns by investing in Compugen, about 43.12% more returns!
Cellectis S has performed better than Sarepta Therapeutics in short term. You could have earned much better returns by investing in Cellectis S, about 27.14% more returns!
Equillium Inc has performed better than Sarepta Therapeutics in short term. You could have earned much better returns by investing in Equillium Inc, about 46.64% more returns!
Guardant Health has performed better than Sarepta Therapeutics in short term. You could have earned much better returns by investing in Guardant Health, about 1.07% more returns!
Henry Schein has performed better than Sarepta Therapeutics in short term. You could have earned much better returns by investing in Henry Schein, about 30.74% more returns!
Immucell Corporation has performed better than Sarepta Therapeutics in short term. You could have earned much better returns by investing in Immucell Corporation, about 31.48% more returns!
Immutep has performed better than Sarepta Therapeutics in short term. You could have earned much better returns by investing in Immutep, about 13.84% more returns!
Iradimed Corporation has performed better than Sarepta Therapeutics in short term. You could have earned much better returns by investing in Iradimed Corporation, about 25.37% more returns!
Sarepta Therapeutics Technical analysis of indicators
Price action analysis of Sarepta Therapeutics (SRPT) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
ADX buy sell signal for Sarepta Therapeutics stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Sarepta Therapeutics in short term and the sell signal is strong.
Sarepta Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Sarepta Therapeutics in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Sarepta Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 17.88 and Sarepta Therapeutics SRPT stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Sarepta Therapeutics SRPT stock. Volume based technical analysis of Sarepta Therapeutics SRPT stock is negative.
Sarepta Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock SRPT Sarepta Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And SRPT Experts View which covers a lot of information including buying and selling signals
SRPT future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Sarepta Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Sarepta Therapeutics (SRPT) Technical (Analysis) Reports Sarepta Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance


